Fertility and Sterility
Volume 92, Issue 4 , Pages 1171-1186, October 2009

Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era

  • Faustino R. Pérez-López, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Zaragoza Faculty of Medicine, Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
    • Corresponding Author InformationReprint requests: Faustino R. Pérez-López, M.D., Ph.D., University of Zaragoza Faculty of Medicine, Domingo Miral s/n, Zaragoza 50009, Spain (FAX: 34-976-76-1734).
  • ,
  • Peter Chedraui, M.D., M.Sc.

      Affiliations

    • Institute of Biomedicine, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador
  • ,
  • Juan J. Gilbert, M.D.

      Affiliations

    • Institute of Biomedicine, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador
  • ,
  • Gonzalo Pérez-Roncero, R.N.

      Affiliations

    • Instituto Ginecológico de Zaragoza, Zaragoza, Spain

Received 5 January 2009; received in revised form 6 February 2009; accepted 12 February 2009. published online 24 August 2009.

Objective

To review scientific publications regarding cardiovascular risk during the menopausal years and that related to currently recognized highly prevalent co-morbid factors within this period.

Methods

Citations were selected from a PubMed search and the authors' files according to their clinical and experimental relevance.

Results and Discussion

Although experimental and some observational data have supported the fact that estrogens are beneficial for the female vascular system, these positive actions have been challenged by the results of the Women's Health Initiative trial and the Million Women Study, which demonstrated an increase in cardiovascular risk and related adverse events. The role of hormone therapy for the menopause has shifted from a preventive use to a limited role in symptom management, for which it remains the most effective intervention. Baseline evaluation of menopausal women should include individual cardiovascular risk assessment, including hypertension, dyslipidemia, elevated body weight, and the metabolic syndrome. Concomitantly, new factors influencing cardiovascular risk have been delineated among postmenopausal women, namely sleeping disorders, depression, vitamin D insufficiency, rheumatoid arthritis, sexual dysfunction, stress, and psychosocial factors. Therefore, a new landscape may be recognized for menopausal women management. Precise evaluation and treatment of each factor should be separately assessed to improve quality of life and reduce cardiovascular disease prevalence. At present, cardiovascular risk reduction strategies are a requisite (albeit underused) for menopausal women. These include education in terms of health, healthy lifestyle, and pharmacologic preventive interventions to reduce co-morbid conditions.

Key Words: Menopause, cardiovascular disease, hormone therapy, depression, sleeping disorders, vitamin D insufficiency, psychosocial factors, obesity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Edward E. Wallach, M.D.Associate Editor

 F.R.P.-L. has nothing to disclose. P.C. has nothing to disclose. J.J.G. has nothing to disclose. G.P.-R. has nothing to disclose.

 Partially supported by the B/017543/08 AECID (“Agencia Española de Cooperación Internacional para el Desarrollo”) grant from the Spanish “Ministerio de Asuntos Exteriores y Cooperación” to the University of Zaragoza (Spain) and the Catholic University of Santiago de Guayaquil (Ecuador).

PII: S0015-0282(09)01353-3

doi:10.1016/j.fertnstert.2009.06.032

Fertility and Sterility
Volume 92, Issue 4 , Pages 1171-1186, October 2009